These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8949380)

  • 1. [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits].
    Boulahrouz R; Autuly V; Charasse C; Le Cacheux P; Ang KS; Ramee MP; Simon P
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1065-8. PubMed ID: 8949380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal vascular lesions and the occurrence of hypertension in patients with IgA nephropathy].
    Boulahrouz R; Stanescu C; Charasse C; Ang KS; Le Cacheux P; Leonetti F; Rioux N; Ramee MP; Simon P
    Arch Mal Coeur Vaiss; 2004; 97(7-8):782-5. PubMed ID: 15506066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
    Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
    Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin basement membrane disease in patients with familial IgA nephropathy.
    Frascá GM; Soverini L; Gharavi AG; Lifton RP; Canova C; Preda P; Vangelista A; Stefoni S
    J Nephrol; 2004; 17(6):778-85. PubMed ID: 15593051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in mesangial IgA glomerulonephritis.
    Rambausek M; Waldherr R; Andrassy K; Ritz E
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():693-7. PubMed ID: 3991561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow up of IgA mesangial deposits glomerulonephritis.
    Imbasciati E; Colasanti G; di Belgioioso GB; Banfi G; Durante A; Ragni A; Ponticelli C; Minetti L; D'Amico G
    Proc Eur Dial Transplant Assoc; 1977; 14():472-7. PubMed ID: 600963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain.
    Velo M; Lozano L; Egido J; Gutierrez-Millet V; Hernando L
    Semin Nephrol; 1987 Dec; 7(4):346-50. PubMed ID: 3445013
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.
    Imakiire T; Kikuchi Y; Yamada M; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
    Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgA nephropathy in patients above 45 years of age. Clinical and morphologic analysis].
    Wagrowska-Danilewicz M; Danilewicz M; Szemraj M
    Pol Merkur Lekarski; 1997 Sep; 3(15):115-8. PubMed ID: 9461706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.